We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+8.77%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.75%
AUM
$19.4B
AUM Growth
+$2.92B
(+18%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
9.31%
Top 10 Holdings %
Top 10 Hldgs %
20.62%
Holding
1,394
New
273
Increased
343
Reduced
316
Closed
453
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$694M |
| 2 |
Philip Morris
PM
|
+$316M |
| 3 |
Johnson & Johnson
JNJ
|
+$315M |
| 4 |
Merck
MRK
|
+$303M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$248M |
| 2 |
Micron Technology
MU
|
+$212M |
| 3 |
RAD
Rite Aid Corporation
RAD
|
+$196M |
| 4 |
Comcast
CMCSA
|
+$165M |
| 5 |
GSK
GSK
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.45% |
| 2 | Energy | 18.88% |
| 3 | Healthcare | 17.92% |
| 4 | Financials | 10.19% |
| 5 | Consumer Staples | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRN
26
DELISTED
Veren
VRN
| $170M | 0.87% |
4,184,747
+3,724,056
| +808% | +$138M |
|
27
Occidental Petroleum
OXY
$55.7B
| $162M | 0.83% |
1,650,972
+1,189,729
| +258% | +$112M |
|
|
AGN
28
DELISTED
Allergan plc
AGN
| $162M | 0.83% |
726,135
+302,912
| +72% | +$62.7M |
|
|
MRO
29
DELISTED
Marathon Oil Corporation
MRO
| $161M | 0.83% |
4,029,479
+3,216,450
| +396% | +$119M |
|
30
HP
HPQ
$26B
| $161M | 0.83% |
10,514,713
-1,778,824
| -14% | -$26.7M |
|
31
Suncor Energy
SU
$77.7B
| $146M | 0.75% |
3,428,728
+2,956,668
| +626% | +$115M |
|
32
Itaú Unibanco
ITUB
$89.8B
| $145M | 0.74% |
25,105,637
+22,066,598
| +726% | +$130M |
|
33
TC Energy
TRP
$70.1B
| $133M | 0.68% |
2,781,445
+2,745,315
| +7,598% | +$128M |
|
|
FRX
34
DELISTED
FOREST LABORATORIES INC
FRX
| $127M | 0.65% |
1,279,835
-255,706
| -17% | -$23.8M |
|
35
Phillips 66
PSX
$82.9B
| $124M | 0.64% |
1,536,114
+1,465,934
| +2,089% | +$121M |
|
36
Duke Energy
DUK
$101B
| $118M | 0.61% |
1,591,669
+761,490
| +92% | +$54.8M |
|
37
Procter & Gamble
PG
$340B
| $116M | 0.6% |
1,476,304
+1,118,263
| +312% | +$90.2M |
|
38
Eli Lilly
LLY
$1.08T
| $114M | 0.58% |
1,829,940
+1,775,394
| +3,255% | +$106M |
|
39
Prudential Financial
PRU
$42.6B
| $111M | 0.57% |
1,245,538
-527,997
| -30% | -$44.4M |
|
40
HCA Healthcare
HCA
$88.4B
| $110M | 0.57% |
1,958,580
+557,000
| +40% | +$29.4M |
|
|
S
41
DELISTED
Sprint Corporation
S
| $107M | 0.55% |
12,518,098
+10,849,321
| +650% | +$95.2M |
|
42
Capital One
COF
$128B
| $102M | 0.53% |
1,239,592
+339,879
| +38% | +$26.4M |
|
43
HDFC Bank
HDB
$123B
| $101M | 0.52% |
8,639,172
+8,577,484
| +13,905% | +$94.1M |
|
44
Pembina Pipeline
PBA
$29.3B
| $97.3M | 0.5% |
2,257,819
+2,218,670
| +5,667% | +$88.9M |
|
45
Marvell Technology
MRVL
$147B
| $94.7M | 0.49% |
6,611,776
-399,270
| -6% | -$6.15M |
|
|
RAI
46
DELISTED
Reynolds American Inc
RAI
| $92.4M | 0.47% |
3,060,724
+1,144,128
| +60% | +$32.8M |
|
47
NetApp
NTAP
$34B
| $91.7M | 0.47% |
2,512,122
+195,507
| +8% | +$7.01M |
|
48
Banco Santander
SAN
$191B
| $88.7M | 0.46% |
+9,370,902
| New | +$86M |
|
49
Banco Bradesco
BBD
$37.4B
| $87.4M | 0.45% |
15,356,770
+14,725,574
| +2,333% | +$86.1M |
|
50
ICICI Bank
IBN
$107B
| $87.3M | 0.45% |
+9,626,326
| New | +$82.8M |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2014 Portfolio in Review
As of Q2 2014, Arrowstreet Capital held 1,394 positions worth $19.4B, up 18% from $16.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Arrowstreet Capital deployed $1.81B of net new capital in Q2 2014, opening 273 new positions and adding to 343 existing holdings. Its largest new stake was Johnson & Johnson: 3,117,484 shares worth $326M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $248M trimmed.
- Arrowstreet Capital's largest Q2 2014 buy was Johnson & Johnson: 3,117,484 shares worth $326M.
- Arrowstreet Capital added most to Apple in Q2 2014, an estimated $694M increase.
- Arrowstreet Capital's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $248M.
- Arrowstreet Capital fully exited Comcast in Q2 2014, selling an estimated $165M.
- Arrowstreet Capital's ten largest holdings make up 21% of its $19.4B portfolio in Q2 2014.
- Arrowstreet Capital opened 273 new positions and closed 453 in Q2 2014.
- Arrowstreet Capital's portfolio value rose 18% quarter-over-quarter to $19.4B.
Based on Arrowstreet Capital's 13F filing for Q2 2014, filed 14 Aug 2014.